"Now, Mr. Chairman, it is time to choose our path. We could accept all of these excuses for inaction and do nothing. The result would be a climate catastrophe. Or we could choose to act now to address ..."
"This law has been a tremendous success if I don't say so myself. Over 80 percent of prescriptions in the United States are generic."
"The proposed rule, if finalized in its current form, would be an important step forward for patient safety."
"I don't believe those claims."
"It is clear that a generic and a brand name label must be the same..."
"I am Henry Waxman from the Hatch-Waxman and I am here to set the record straight."
"I still believe that to be true. However, I don't think allowing a temporary period of time in which the labels may be different thwarts the sameness goals."
"Sameness in labeling is important but also finding out about new problems is important."
"I think there needs to be sameness in labeling."
"We don't want to scare consumers to think, oh, if I take a generic, I may be taking something that is not as safe."
"Whoever you met with before is interesting but don't you now have to have comments from everybody with a proposed rule and take those comments into consideration?"
"Thank you very much, Mr. Chairman."